Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum
NCT04889014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233
Last updated 2021-05-17
Summary
The purpose of this study is to evaluate the use of personal genomic educational testing (PGET) on student knowledge and clinical skills surrounding pharmacogenomic testing to ensure it is of educational benefit to our student population. Students will be provided the opportunity to opt-in to test their own pharmacogenomic panel while participating in the standard curriculum. Students will have the option of using their own reports or dummy reports during classroom activities. Our hypothesis is that those students who have their own pharmacogenomics tested will show better overall performance.
Conditions
- Healthy
Interventions
- GENETIC
-
Personal genomic educational testing (PGET)
PGET consisted of a panel of pharmacogenomic variants
- GENETIC
-
No personal genomic educational testing (NPGET)
Lack of pharmacogenomic testing
Sponsors & Collaborators
-
University of Arizona
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-03
- Primary Completion
- 2021-03-01
- Completion
- 2021-03-01
More Related Trials
-
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
NCT02081872 ·Status: UNKNOWN
-
Pharmacogenetic Testing and Chronic Pain
NCT05259865 ·Status: SUSPENDED
-
Pharmacogenomics Registry to Assess Clinical Utility
NCT02374840 ·Status: UNKNOWN
-
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825 ·Status: RECRUITING
-
The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
NCT06455384 ·Status: RECRUITING ·Phase: NA
-
Pharmacogenetic Testing for Medication Management.
NCT02559193 ·Status: WITHDRAWN
-
Pharmacogenomics to Improve Supportive Care Symptoms.
NCT06856122 ·Status: ENROLLING_BY_INVITATION
-
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
NCT02095769 ·Status: UNKNOWN
-
Clinical Trial of the Sequence of Cardiovascular Genetic Counseling and Testing
NCT05422573 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder
NCT01452061 ·Status: COMPLETED
-
Educational Video for Genetic Testing
NCT05472714 ·Status: COMPLETED ·Phase: NA
-
Prenatal Computer-Aided Genetics Education Module
NCT03449225 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
NCT02487888 ·Status: UNKNOWN ·Phase: NA
-
Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes
NCT01274065 ·Status: COMPLETED
-
Adult Patients With Undiagnosed Conditions and Their Responses to Clinically Uncertain Results From Exome Sequencing
NCT03605004 ·Status: COMPLETED
-
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
NCT03729180 ·Status: RECRUITING ·Phase: NA
-
Transition From Research to Disclosure in Human Genetics
NCT00505466 ·Status: COMPLETED
-
Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
NCT01375543 ·Status: COMPLETED
-
Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics
NCT00341718 ·Status: COMPLETED
-
Clinical Implementation of Carrier Status Using Next Generation Sequencing
NCT01902901 ·Status: COMPLETED ·Phase: NA
-
Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
NCT04426253 ·Status: UNKNOWN
-
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
NCT00953667 ·Status: COMPLETED ·Phase: NA
-
Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations
NCT02789527 ·Status: COMPLETED ·Phase: NA
-
Research for Individualized Therapeutics in Rare Genetic Disease
NCT05236595 ·Status: ENROLLING_BY_INVITATION
-
Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension
NCT02988245 ·Status: UNKNOWN ·Phase: PHASE2